Published in Haemostasis on January 01, 1974
Ultrastructural aspects of interactions of platelets with microcrystalline collagen. Am J Pathol (1976) 0.93
Microcrystalline collagen hemostat (MCCH) and wound healing. Ann Surg (1976) 0.75
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med (1999) 4.61
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med (1999) 3.39
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science (1993) 2.95
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther (2000) 2.12
Overdosage of opiate from patient controlled analgesia devices. BMJ (1994) 1.89
Guide to materials for use in teaching clinical nutrition in schools of medicine, dentistry, and public health. Am J Clin Nutr (1983) 1.77
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther (1998) 1.52
Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci U S A (1985) 1.47
Extradural sufentanil by patient-controlled analgesia or nurse-administered compared with optimal morphine in a high dependency unit: effects on oxygenation and pain relief after abdominal surgery. Br J Anaesth (1994) 1.39
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci U S A (1989) 1.35
Morphologic manifestations of blood-solid interfacial reactions. A scanning and transmission electron microscopic study. Lab Invest (1969) 1.34
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc Natl Acad Sci U S A (1990) 1.28
United States (US) multi-center study to assess the validity and reliability of the Spinal Cord Independence Measure (SCIM III). Spinal Cord (2011) 1.22
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther (1996) 1.12
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A. Blood (1993) 1.10
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther (1995) 1.09
Some species differences in fibrinolysis and blood coagulation. J Biomed Mater Res (1971) 1.08
Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci U S A (1978) 1.04
Platelet-platelet interaction: relationship to hemostasis and thrombosis. Fed Proc (1967) 1.04
Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood (1996) 1.03
Venous thrombosis on prosthetic surfaces. Evolution and blood coagulation studies in a nonhuman primate model. Am J Pathol (1974) 1.03
Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J Lab Clin Med (1983) 1.02
Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays. Thromb Res (1978) 1.02
Plasma levels of platelet aggregating factor/vom Willebrand factor in various species. Thromb Res (1977) 1.01
Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction. Thromb Res (1974) 1.01
Heparin neutralization of PGI2: effects upon platelets. Science (1979) 1.01
The endothelium: roles in thrombosis and hemostasis. Arch Pathol Lab Med (1977) 1.00
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc Natl Acad Sci U S A (1987) 0.99
The platelet: membrane and surface reactions. Annu Rev Physiol (1976) 0.98
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony. Thromb Haemost (2000) 0.98
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci U S A (1995) 0.97
Platelet response to six agglutinating agents: species similarities and differences. Exp Mol Pathol (1967) 0.95
Effects of platelets and certain platelet components on growth of cultured human endothelial cells. Thromb Res (1975) 0.94
Malnutrition, hunger, and behavior. I. Malnutrition and learning. J Am Diet Assoc (1973) 0.94
Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor. Blood (1980) 0.93
Lyophilized platelets: continued development. Transfus Sci (2000) 0.93
Ultrastructural aspects of interactions of platelets with microcrystalline collagen. Am J Pathol (1976) 0.93
Study of the reactions of blood with artificial surfaces. Use of the thrombogenerator. Lab Invest (1974) 0.92
Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype. Am J Pathol (1992) 0.92
The interaction of blood hemostitic elements with aritificial surfaces. Prog Hemost Thromb (1972) 0.92
Fibrinogen--its role in platelet agglutination and agglutinate stability. A study of congenital aibrinogenemia. Lab Invest (1966) 0.91
Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model. Lab Invest (1988) 0.91
Effects of certain purified plasma proteins on the compatibility of glass with blood. Am J Pathol (1973) 0.90
Malnutrition, hunger, and behavior. II. Hunger, school feeding programs, and behavior. J Am Diet Assoc (1973) 0.90
Freeze-etch observations on the plasma membrane and other structures of normal and abnormal platelets. Am J Pathol (1973) 0.89
Sites of acetylation of sickle cell hemoglobin by aspirin. Proc Natl Acad Sci U S A (1974) 0.89
Effects of heparin on platelet aggregation and release and thromboxane A2 production. Am J Pathol (1981) 0.88
Cross-sectional study of nutrition knowledge and attitudes of medical students at three points in their medical training at 11 southeastern medical schools. Am J Clin Nutr (1988) 0.87
Unbalanced globin chain synthesis in congenital dyserythropoietic anemia. Blood (1973) 0.87
Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci U S A (1983) 0.87
Characterization of human platelets separated from blood by ADP-induced aggregation. Am J Pathol (1975) 0.86
Comparison of certain functions of human platelets separated from blood by various means. Am J Pathol (1974) 0.86
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction. Thromb Diath Haemorrh (1972) 0.86
Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay. Ann N Y Acad Sci (1981) 0.85
Multiple active forms of thrombin: binding to platelets and effects on platelet function. Proc Natl Acad Sci U S A (1976) 0.85
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis (1990) 0.85
Inhibition of human platelet-collagen adhesion reaction by amitriptyline and imipramine. Proc Soc Exp Biol Med (1974) 0.85
Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome. J Pediatr (1978) 0.85
Development of coronary atherosclerosis in swine with severe hypercholesterolemia. Lack of influence of von Willebrand factor or acute intimal injury. Arteriosclerosis (1986) 0.85
Perceived risks of radioactive waste transport through Oregon: results of a statewide survey. Risk Anal (1994) 0.85
Platelet ATPase activities. II. ATPase activities of isolate platelet membrane fractions. Am J Pathol (1969) 0.84
Adhesion of human blood platelets to glass and polymer surfaces. I. Studies with platelets in plasma. Haemostasis (1974) 0.84
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. Antisense Nucleic Acid Drug Dev (1998) 0.84
Interaction of plasma proteins with artificial surfaces: protein adsorption isotherms. J Lab Clin Med (1978) 0.84
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B. Thromb Haemost (1997) 0.84
Hemoglobin Abraham Lincoln, beta32 (B14) leucine leads to proline. An unstable variant producing severe hemolytic disease. J Clin Invest (1973) 0.84
Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody. Semin Thromb Hemost (1985) 0.83
Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol (1995) 0.82
Adhesion of human blood platelets to glass polymer surfaces. II. Demonstration of the presence of a natural platelet adhesion inhibitor in plasma and serum. Haemostasis (1976) 0.82
The adhesion of platelets to subendothelium, collagen and artifilial surfaces. Semin Thromb Hemost (1976) 0.82
Platelet retention in particle-filled columns: effects of particle type, plasma proteins, and platelet reactivity. Am J Clin Pathol (1971) 0.82
Acetylcholinesterase, choline acetyltransferase, and the postulated acetylcholine receptor of canine platelets. Biochem Pharmacol (1976) 0.82
von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis. Mayo Clin Proc (1991) 0.82
Heparin potentiates synthesis of thromboxane A2 in human platelets. Adv Prostaglandin Thromboxane Res (1980) 0.82
Cellular growth, nutrition and development. Pediatrics (1970) 0.82
Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia. Pediatr Res (1976) 0.81
Sickle hemoglobin in combination with HbJBangkok (alphaA2beta56-2gly leads to asp). Blood (1974) 0.81
Thrombogenicity of some biomedical materials: platelet-interface reactions. J Biomed Mater Res (1969) 0.81
Blood compatibility of biomaterials: evaluation of a simple screening test. Biomater Med Devices Artif Organs (1973) 0.81
Acetylcholine, cholinesterase activity, and the aggregability of human platelets. Proc Soc Exp Biol Med (1970) 0.81
Unbalanced globin chain synthesis by Hb Lincoln Park (anti-Lepore) reticulocytes. Am J Hematol (1978) 0.81
Reactions of blood with nonbiologic surfaces. Ultrastructural and clotting studies with normal and coagulation factor deficient bloods. Am J Pathol (1972) 0.81
Platelet ATPase activities. I. Ecto-ATPases of intact platelets and their possible role in aggregation. Am J Pathol (1969) 0.81
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs. Thromb Haemost (2001) 0.81
Coronary atherosclerosis in the pig. Induced plaque injury and platelet response. Arteriosclerosis (1990) 0.81
Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new variant with increased oxygen affinity. Biochim Biophys Acta (1980) 0.81
Alteration of platelet adhesion to glass in vascular disorders and certain other diseases. Am J Clin Pathol (1972) 0.81
Intracellular function in rehydrated lyophilized platelets. Br J Haematol (2000) 0.80
Creation of a regional medical-nutrition education network. Am J Clin Nutr (1989) 0.80
Effect of a new antiaggregating chemical on the structure and function of the human platelet. Am J Pathol (1971) 0.80
Lessons to be learned: a case study approach. 'Spontaneous' intraperitoneal bladder rupture in a psychiatric patient--with diagnostic difficulties. J R Soc Promot Health (2001) 0.80
Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin. Proc Natl Acad Sci U S A (1981) 0.80
Some methods for in vitro estimation of the blood compatibility of biomaterials. Bull N Y Acad Med (1972) 0.80
Regulation of hemoglobin beta-chain synthesis in bone marrow erythroid cells by alpha chains. Proc Natl Acad Sci U S A (1973) 0.80
Some properties of endothelial cells isolated from human umbilical cord vein. Ser Haematol (1973) 0.80
Reaction of blood with artificial surfaces of hemodialyzers. Studies of human blood with platelet defects or coagulation factor deficiencies. Biomater Med Devices Artif Organs (1978) 0.79